A new study published by Cell Death & Disease provides fresh insight into how the endocannabinoid system may influence male fertility, identifying a previously underappreciated role for the cannabinoid receptor CB1 in human sperm chromatin remodeling. The research was conducted by scientists from Università Politecnica delle Marche, Universidad de León, University of Macerata, and collaborating institutions in Italy and Spain.

Using advanced confocal and Airyscan microscopy, researchers mapped the precise distribution of CB1 in human sperm, resolving inconsistencies left by earlier imaging techniques. The receptor was observed in a dotted pattern along the sperm tail, in select midpieces, and in discrete regions of the head. Comparative analysis across species showed that while CB1 appears in the sperm tail of both invertebrates and vertebrates, its presence in the sperm head is restricted to roosters and mammals.

In mammals, the study identified a population of CB1 receptors located inside the sperm cell, beneath the plasma and outer acrosomal membranes and extending toward the nucleus. Notably, this intracellular signal remained even after the acrosome reaction, suggesting CB1 may have functions beyond motility and fertilization mechanics.

Building on earlier animal research, the team examined whether CB1 influences chromatin structure in human sperm. Activation of CB1 with a selective agonist (something done naturally via cannabis) increased histone H4 acetylation, restoring normal levels in samples from men with asthenoteratozoospermia. While another endocannabinoid reduced DNA fragmentation, CB1 activation itself did not, indicating distinct regulatory pathways.

Taken together, the findings point to a conserved role for CB1 in chromatin dynamics during sperm development, offering new insight into the molecular processes underlying male reproductive health.